Literature DB >> 2592357

The distribution, purification, and pharmacological action of an amphibian neuromedin U.

J Domin1, Y G Yiangou, R A Spokes, A Aitken, K B Parmar, B J Chrysanthou, S R Bloom.   

Abstract

The distribution, primary structure, and relative biological activity of neuromedin U has been determined from the frog Rana temporaria. Following sequential column chromatography of a gastrointestinal extract, the peptide was sufficiently pure to enable characterization by micro-sequence analysis. The entire sequence was found to be an icosapentapeptide which displays marked sequence similarity to both porcine and rat neuromedin U. The sequence of the biologically active, COOH-terminal region is almost completely conserved across all species. Synthetic, COOH-terminally amidated amphibian neuromedin U, like the porcine and rat peptides, stimulates rat uterine contraction in vitro thereby fulfilling the criterion upon which the nomenclature of this peptide family is based. In addition, the peptide demonstrates parallel pressor effects when infused systemically into rats. The high degree of amino acid sequence conservation is indicative of strong evolutionary pressure acting to retain the presence of this possibly physiologically important peptide across the vertebrate subphylum.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2592357

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

Review 1.  Emerging pharmacology and physiology of neuromedin U and the structurally related peptide neuromedin S.

Authors:  J D Mitchell; J J Maguire; A P Davenport
Journal:  Br J Pharmacol       Date:  2009-06-10       Impact factor: 8.739

2.  Localisation of NMU1R and NMU2R in human and rat central nervous system and effects of neuromedin-U following central administration in rats.

Authors:  Jane Gartlon; Philip Szekeres; Mark Pullen; Henry M Sarau; Nambi Aiyar; Usman Shabon; David Michalovich; Klaudia Steplewski; Cathy Ellis; Nabil Elshourbagy; Mark Duxon; Tracey E Ashmeade; David C Harrison; Paul Murdock; Shelagh Wilson; Abdel Ennaceur; Alan Atkins; Christian Heidbreder; Jim J Hagan; A Jackie Hunter; Declan N C Jones
Journal:  Psychopharmacology (Berl)       Date:  2004-06-16       Impact factor: 4.530

Review 3.  Neuromedin U, a Key Molecule in Metabolic Disorders.

Authors:  Hitoshi Teranishi; Reiko Hanada
Journal:  Int J Mol Sci       Date:  2021-04-19       Impact factor: 5.923

Review 4.  Neuromedin U: potential roles in immunity and inflammation.

Authors:  Yuan Ye; Zongan Liang; Luzheng Xue
Journal:  Immunology       Date:  2020-09-16       Impact factor: 7.397

5.  Neuromedins U and S involvement in the regulation of the hypothalamo-pituitary-adrenal axis.

Authors:  Ludwik K Malendowicz; Agnieszka Ziolkowska; Marcin Rucinski
Journal:  Front Endocrinol (Lausanne)       Date:  2012-12-05       Impact factor: 5.555

6.  Insights Into the Research Status of Neuromedin U: A Bibliometric and Visual Analysis From 1987 to 2021.

Authors:  Xueping Qi; Peidong Liu; Yanjie Wang; Jinmei Xue; Yunfang An; Changqing Zhao
Journal:  Front Med (Lausanne)       Date:  2022-02-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.